We are live on ! Find out more
OCMI

Oaktop Capital Management II Portfolio holdings

AUM $1.34B
1-Year Est. Return 114.5%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$453M
AUM Growth
+$27.2M
Cap. Flow
+$299K
Cap. Flow %
0.07%
Top 10 Hldgs %
91.57%
Holding
20
New
Increased
1
Reduced
Closed
1

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$701K

Sector Composition

Rank Sector Weight
1 Technology 68.65%
2 Healthcare 12.13%
3 Industrials 7.11%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
1
Lam Research
LRCX
$316B
$105M 23.2%
3,165,040
KLAC icon
2
KLA
KLAC
$222B
$77.6M 17.16%
4,007,500
MXIM
3
DELISTED
Maxim Integrated Products
MXIM
$50.2M 11.09%
742,375
BMY icon
4
Bristol-Myers Squibb
BMY
$129B
$41M 9.06%
679,991
EGAN icon
5
eGain
EGAN
$186M
$35.9M 7.94%
2,536,843
ASPN icon
6
Aspen Aerogels
ASPN
$339M
$32.2M 7.11%
2,939,758
CEVA icon
7
CEVA Inc
CEVA
$831M
$24.9M 5.49%
631,377
PRGS icon
8
Progress Software
PRGS
$1.75B
$22.5M 4.96%
612,526
VMW
9
DELISTED
VMware, Inc
VMW
$13.3M 2.94%
92,500
PETS icon
10
PetMed Express
PETS
$42.3M
$11.8M 2.61%
373,675
SONO icon
11
Sonos
SONO
$2.09B
$9.87M 2.18%
650,000
DELL icon
12
Dell
DELL
$239B
$9.52M 2.1%
277,441
AVGO icon
13
Broadcom
AVGO
$1.76T
$5.83M 1.29%
160,000
GRMN
14
Garmin
GRMN
$56.9B
$4.55M 1.01%
48,000
XLE icon
15
State Street Energy Select Sector SPDR ETF
XLE
$39B
$3M 0.66%
200,000
INTC icon
16
Intel
INTC
$413B
$1.71M 0.38%
33,010
AXDX
17
DELISTED
Accelerate Diagnostics
AXDX
$1.65M 0.37%
15,500
BMY.RT
18
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.59M 0.35%
704,991
+350,000
+99% +$1,000K
ANIK icon
19
Anika Therapeutics
ANIK
$215M
$442K 0.1%
12,500
BBBY
20
Bed Bath & Beyond
BBBY
$479M
-27,128
Closed -$701K

Similar funds

Oaktop Capital Management II's Q3 2020 Portfolio in Review

As of Q3 2020, Oaktop Capital Management II held 20 positions worth $453M, up 6.4% from $425M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Oaktop Capital Management II's Q3 2020 filing shows 1 increased and 1 closed positions. The largest sale was Bed Bath & Beyond, an estimated $701K.

By sector, the portfolio is most concentrated in Technology at 69% of assets, down from 70% a quarter earlier, followed by Healthcare and Industrials.

  • Oaktop Capital Management II added most to Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020, an estimated $1,000K increase.
  • Oaktop Capital Management II fully exited Bed Bath & Beyond in Q3 2020, selling an estimated $701K.
  • Oaktop Capital Management II's ten largest holdings make up 92% of its $453M portfolio in Q3 2020.
  • Oaktop Capital Management II opened 0 new positions and closed 1 in Q3 2020.
  • Oaktop Capital Management II's portfolio value rose 6.4% quarter-over-quarter to $453M.

Based on Oaktop Capital Management II's 13F filing for Q3 2020, filed 12 Nov 2020.